TRACON Pharmaceuticals, Inc.
TCON · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6,270 | $7,891 | $8,564 | $7,763 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $240 | $511 | $526 | $577 |
| Total Curr. Assets | $6,510 | $8,402 | $9,090 | $8,340 |
| Property Plant & Equip (Net) | $30 | $33 | $942 | $40 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $73 | $73 | $72 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $860 | $847 | $0 | $961 |
| Total NC Assets | $890 | $953 | $1,015 | $1,073 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7,400 | $9,355 | $10,105 | $9,413 |
| Liabilities | – | – | – | – |
| Payables | $2,652 | $2,681 | $2,544 | $10,622 |
| Short-Term Debt | $0 | $0 | $236 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | -$236 | $0 |
| Other Curr. Liab. | $7,239 | $7,769 | $7,402 | $1,080 |
| Total Curr. Liab. | $9,891 | $10,450 | $10,182 | $11,702 |
| LT Debt | $0 | $0 | $732 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $598 | $667 | $0 | $795 |
| Total NC Liab. | $598 | $667 | $732 | $795 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $236 | $0 |
| Total Liabilities | $10,489 | $11,117 | $10,914 | $12,497 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $3 | $44 | $31 |
| Retained Earnings | -$246,506 | -$243,667 | -$240,499 | -$240,938 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $243,414 | $241,902 | $239,646 | $237,823 |
| Total Equity | -$3,089 | -$1,762 | -$809 | -$3,084 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $7,400 | $9,355 | $10,105 | $9,413 |
| Net Debt | -$6,270 | -$7,891 | -$7,596 | -$7,763 |